Assuming continual spend, they'll be down to around $6m in the kitty at the end of March. What's the feeling on a CR before phase 1 trials?
Dr. Andrews has mentioned in a recent interview that they won't need it but it may be too good to refuse some extra cash before some decent news flow.
Thoughts?
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-2
Add NSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.350M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 134250 | 3.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.0¢ | 213161 | 1 |
View Market Depth
| Last trade - 10.07am 10/07/2024 (20 minute delay) ? |
| NSB (ASX) Chart |
Day chart unavailable